02/14/2025
6:00 AM | Kluge Andreas (Filed by)
Telix Pharmaceuticals (Subject)
Telix Pharmaceuticals Ltd (Subject)
| Form SCHEDULE 13G | |
02/14/2025
6:00 AM | Behrenbruch Christian (Filed by)
Telix Pharmaceuticals (Subject)
Telix Pharmaceuticals Ltd (Subject)
| Form SCHEDULE 13G | |
02/13/2025
7:09 AM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2025
6:19 AM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/27/2025
3:40 PM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/13/2025
5:49 AM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024
3:05 PM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024
5:16 AM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/19/2024
6:30 AM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
6:00 AM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024
11:15 PM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form EFFECT | |
11/12/2024
4:00 PM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form SEC STAFF ACTION | |
11/12/2024
12:33 PM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form CERT | |
10/29/2024
6:03 PM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form 20FR12B/A | |
10/17/2024
4:23 PM | JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by)
Telix Pharmaceuticals (Subject)
Telix Pharmaceuticals Ltd (Subject)
| Form F-6
Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts | |
10/17/2024
3:05 PM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form 20FR12B | |
06/14/2024
11:19 AM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form RW | |
06/14/2024
7:12 AM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form RW | |
06/05/2024
5:43 AM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form F-1/A | |
05/30/2024
5:31 AM | JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by)
Telix Pharmaceuticals (Subject)
Telix Pharmaceuticals Ltd (Subject)
| Form F-6
Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts | |
05/17/2024
5:24 AM | Telix Pharmaceuticals (Filer)
Telix Pharmaceuticals Ltd (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
